Augustine Therapeutics

Augustine Therapeutics

Biotechnology Research

Leuven, Flemish Region 2,686 followers

Innovative Therapies for Neuromuscular and Neurodegenerative Disorders

About us

Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies and neurodegenerative disorders. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by Asabys Partners, Eli Lilly and Company, V-Bio Ventures, PMV, AdBio Partners, VIB, Gemma Frisius Fund and CMT Research Foundation. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Leuven, Flemish Region
Type
Privately Held
Founded
2019

Locations

Employees at Augustine Therapeutics

Updates

Similar pages

Funding